176 related articles for article (PubMed ID: 16314654)
1. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
Bibb J; Hromas R; Rabinowitz I
J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654
[No Abstract] [Full Text] [Related]
2. False-positive FDG-PET findings due to bone metastasis from prostate cancer in staging of non-Hodgkin's lymphoma.
Inoue Y; Tamaki H; Yamagami T; Iwasaki H; Nakatsuka S; Soma T
Eur J Haematol; 2007 Jul; 79(1):88-90. PubMed ID: 17532762
[No Abstract] [Full Text] [Related]
3. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.
Tempescul A; Querellou S; Ianotto JC; Boisramé S; Valette G; Berthou C
Ann Hematol; 2010 Jun; 89(6):635-7. PubMed ID: 19844711
[No Abstract] [Full Text] [Related]
5. Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP
Leuk Lymphoma; 2005 Mar; 46(3):477-9. PubMed ID: 15621843
[No Abstract] [Full Text] [Related]
6. [Diagnosis and therapy of malignant thyroid lymphoma].
Kuma K; Matsuzuka F
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1190-5. PubMed ID: 9379098
[No Abstract] [Full Text] [Related]
7. [An update on recent developments in non-Hodgkin's lymphoma].
Bouabdallah K; Milpied N
Bull Cancer; 2007 Jan; 94(1):43-52. PubMed ID: 17237004
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
Schmits R; Glass B; Trümper L; Pfreundschuh M;
Ann Hematol; 2001; 80 Suppl 3():B77-83. PubMed ID: 11757714
[No Abstract] [Full Text] [Related]
10. Lymphoma 2000. The First International Symposium on Biology and Treatment of Aggressive Lymphomas: The stagnation seems to be over.
Pfreundschuh M
Ann Hematol; 2001; 80 Suppl 3():B1-2. PubMed ID: 11757687
[No Abstract] [Full Text] [Related]
11. Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.
Bertè R; Vallisa D; Civardi G; Moroni CF; Lazzaro A; Cavanna L
Acta Haematol; 2001; 106(3):141-2. PubMed ID: 11713384
[No Abstract] [Full Text] [Related]
12. Primary endometrial non-Hodgkin's lymphoma treated by chemotherapy and radiotherapy.
Guldrís EM; Vázquez P; Fernández A
Acta Obstet Gynecol Scand; 2013 May; 92(5):606. PubMed ID: 23398244
[No Abstract] [Full Text] [Related]
13. Sarcoid-like reaction in the spleen following chemotherapy for non-Hodgkin's lymphoma.
Reilly TB; Schuster DM; Starsiak MD; Kost CB; Halkar RK
Clin Nucl Med; 2007 Jul; 32(7):569-71. PubMed ID: 17581351
[No Abstract] [Full Text] [Related]
14. High incidence of false-positive PET scans in patients with aggressive non-Hodgkin's lymphoma treated with rituximab-containing regimens.
Han HS; Escalón MP; Hsiao B; Serafini A; Lossos IS
Ann Oncol; 2009 Feb; 20(2):309-18. PubMed ID: 18842613
[TBL] [Abstract][Full Text] [Related]
15. [Non-pegylated liposomal doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab for the treatment of non-Hodgkin's lymphoma: study of 26 patients].
Moreno M; Sancho JM; Gardella S; Coll R; García O; Gallardo D; Ribera JM
Med Clin (Barc); 2010 Jan; 134(2):72-5. PubMed ID: 19913261
[TBL] [Abstract][Full Text] [Related]
16. [Thyroid malignant lymphoma].
Noh JY; Shimizu T; Ito K
Nihon Rinsho; 2006 May; Suppl 1():482-4. PubMed ID: 16776195
[No Abstract] [Full Text] [Related]
17. Intensive chemotherapy with rituximab is safe and effective in AIDS non-Hodgkin's lymphoma.
Rey J; Charbonnier A; Schiano de Colella JM; Stoppa AM; Poizot-Martin I; Gastaut JA; Costello RT
AIDS; 2003 Sep; 17(13):2006-7. PubMed ID: 12960844
[No Abstract] [Full Text] [Related]
18. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
Ustaalioglu BB; Bilici A; Seker M; Canpolat N; Ozdemir N; Salepci T; Gumus M
Leuk Res; 2010 Apr; 34(4):e108-10. PubMed ID: 19931906
[No Abstract] [Full Text] [Related]
19. Non-Hodgkin's lymphoma: present status and future prospects.
Habermann TM
Hosp Pract (1995); 1999 Dec; 34(13):81-4, 87-8. PubMed ID: 10611900
[TBL] [Abstract][Full Text] [Related]
20. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
Provencio M; Fayad LE
Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
[No Abstract] [Full Text] [Related]
[Next] [New Search]